Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#161 / 200 Total
PASG - Passage Bio Inc - Stock Price Chart
TickerPASG [NASD]
CompanyPassage Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap73.04MEPS (ttm)-1.53
P/E-EPS this Y43.55%
Forward P/E-EPS next Y23.62%
PEG-EPS past 5Y-46.23%
P/S-EPS next 5Y-
P/B0.70EPS Q/Q52.79%
Dividend-Sales Q/Q-
Insider Own29.27%Inst Own32.76%
Insider Trans-0.19%Inst Trans-5.98%
Short Float4.03%EarningsMay 14/b
Analyst Recom1.00Target Price6.75
Avg Volume300.68K52W Range0.58 - 1.79
Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Forman Mark SCHIEF MEDICAL OFFICERFeb 13 '24Sale0.971,6381,58948,631Feb 13 07:34 PM
Borthwick KathleenSVP, INTERIM CFOFeb 13 '24Sale0.971,4701,42628,466Feb 13 07:36 PM
Forman Mark SChief Medical OfficerJan 02 '24Sale0.9115,81314,39045,269Jan 03 04:21 PM
Cale Edgar B.GC & Corporate SecretaryJan 02 '24Sale0.9115,81314,39045,995Jan 03 04:19 PM
King SimonaChief Financial OfficerJul 28 '23Option Exercise0.0031,250035,447Aug 01 04:36 PM
DZSI - DZS Inc - Stock Price Chart
TickerDZSI [NASD, RUT]
CompanyDZS Inc
CountryUSA
IndustryCommunication Equipment
Market Cap40.79MEPS (ttm)-1.76
P/E-EPS this Y1.32%
Forward P/E25.40EPS next Y-87.01%
PEG-EPS past 5Y-
P/S0.10EPS next 5Y20.00%
P/B0.31EPS Q/Q-398.55%
Dividend-Sales Q/Q17.88%
Insider Own46.95%Inst Own21.13%
Insider Trans0.00%Inst Trans-
Short Float7.70%Earnings-
Analyst Recom1.00Target Price6.50
Avg Volume181.44K52W Range0.95 - 6.97
DZS, Inc. engages in the provision of packet-based mobile transport and broadband access solutions. It includes the research, development, test, sale, manufacture, and support of communications equipment in the following areas: broadband access, Ethernet switching, mobile front haul and back haul, passive optical LAN, and software defined networks (SDN) and network function virtualization (NFV) solutions. The company was founded in June 1999 and is headquartered in Plano, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Alonso MiguelChief Product OfficerJun 10 '23Option Exercise0.006,250019,039Jun 13 02:59 PM
Ferguson Justin K.Chief Legal OfficerJun 10 '23Option Exercise0.0012,500038,797Jun 13 02:57 PM
VOGT CHARLES DPresident & CEOJun 10 '23Option Exercise0.0014,8160109,068Jun 13 02:56 PM
Kawecki Misty DawnChief Financial OfficerMay 30 '23Option Exercise0.004,138026,245Jun 01 04:56 PM
VOGT CHARLES DPresident & CEOMay 30 '23Option Exercise0.0018,3910102,096Jun 01 04:54 PM
BDSX - Biodesix Inc - Stock Price Chart
TickerBDSX [NASD]
CompanyBiodesix Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap164.01MEPS (ttm)-0.55
P/E-EPS this Y42.97%
Forward P/E-EPS next Y27.40%
PEG-EPS past 5Y8.42%
P/S2.99EPS next 5Y-
P/B-EPS Q/Q41.75%
Dividend-Sales Q/Q63.63%
Insider Own59.22%Inst Own17.27%
Insider Trans-0.17%Inst Trans15.77%
Short Float0.74%EarningsMay 08/a
Analyst Recom1.00Target Price3.10
Avg Volume144.92K52W Range1.03 - 2.21
Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Boulder, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hutton ScottPresident & CEOMay 09 '24Sale1.483,7645,569483,780May 10 05:04 PM
Cowie Robin HarperCFO, Sec'y & TreasurerMay 09 '24Sale1.489801,450171,680May 10 05:04 PM
O'Kane KieranChief Commercial OfficerMay 09 '24Sale1.4846869275,524May 10 05:05 PM
Pestano Gary AnthonyChief Development OfficerMay 09 '24Sale1.48434642124,248May 10 05:06 PM
Vazquez ChrisChief Accounting OfficerMay 09 '24Sale1.482443619,915May 10 05:06 PM
XNCR - Xencor Inc - Stock Price Chart
TickerXNCR [NASD, RUT]
CompanyXencor Inc
CountryUSA
IndustryBiotechnology
Market Cap1.42BEPS (ttm)-2.19
P/E-EPS this Y-71.19%
Forward P/E-EPS next Y20.43%
PEG-EPS past 5Y-9.81%
P/S8.76EPS next 5Y-
P/B2.32EPS Q/Q-9.33%
Dividend-Sales Q/Q-32.47%
Insider Own2.63%Inst Own104.17%
Insider Trans-8.52%Inst Trans-2.39%
Short Float11.12%EarningsMay 09/a
Analyst Recom1.50Target Price34.64
Avg Volume728.05K52W Range16.49 - 28.96
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Valente NancyEVP, Chief Development OfficerMay 02 '24Sale23.584,745111,87255,115May 03 04:06 PM
Dahiyat Bassil IPRESIDENT & CEOMar 11 '24Sale23.502,74164,418351,894Mar 12 04:03 PM
Desjarlais John RSR. VICE PRESIDENT & CSOMar 11 '24Sale23.501,28030,082186,433Mar 12 04:05 PM
Eckert CeliaSVP, GENERAL COUNSELMar 11 '24Sale23.5085019,97745,465Mar 12 04:06 PM
Kuch John JSR. VICE PRESIDENT & CFOMar 11 '24Sale23.5084919,953121,070Mar 12 04:08 PM
RDZN - Roadzen Inc - Stock Price Chart
TickerRDZN [NASD]
CompanyRoadzen Inc
CountryUSA
IndustrySoftware - Application
Market Cap253.23MEPS (ttm)0.05
P/E68.39EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-1672.89%
Dividend-Sales Q/Q-
Insider Own74.87%Inst Own8.82%
Insider Trans0.05%Inst Trans1.33%
Short Float0.10%Earnings-
Analyst Recom-Target Price-
Avg Volume19.97K52W Range2.70 - 17.00
TodayInitiated Maxim Group Buy $10
Roadzen, Inc. operates as an insurance technology company. It offers auto insurance services through artificial intelligence technology. The company was founded by Rohan Malhotra on May 7, 2015 and is headquartered in Burlingame, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHAH AJAYDirectorDec 13 '23Buy3.1010,00031,000487,399Dec 15 11:12 AM
SHAH AJAYDirectorDec 12 '23Buy3.085,00015,400477,399Dec 15 11:12 AM
VedBrat SupurnaDirectorDec 11 '23Buy2.912,0005,8208,250Dec 15 10:00 AM
VedBrat SupurnaDirectorDec 08 '23Buy3.113,1009,6416,250Dec 15 10:00 AM
VedBrat SupurnaDirectorDec 07 '23Buy3.203,15010,0803,150Dec 15 10:00 AM
MINM - Minim Inc - Stock Price Chart
TickerMINM [NASD]
CompanyMinim Inc
CountryUSA
IndustryCommunication Equipment
Market Cap9.05MEPS (ttm)-8.18
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-139.10%
P/S0.57EPS next 5Y-
P/B-EPS Q/Q45.66%
Dividend-Sales Q/Q-94.05%
Insider Own58.51%Inst Own2.05%
Insider Trans-Inst Trans-52.76%
Short Float8.40%Earnings-
Analyst Recom1.00Target Price8.75
Avg Volume617.03K52W Range0.60 - 10.28
Apr-12-24 10:53PM MINM Stock Earnings: Minim Reported Results for Q4 2023 (InvestorPlace) -11.17%
Apr-04-24 07:00AM e2Companies Identifies Global Power Leader Cummins Inc. as Strategic Supplier for the R3Di® System (GlobeNewswire)
Mar-12-24 04:05PM Minim Announces Merger Agreement with e2Companies (GlobeNewswire) +9.15%
Mar-01-24 08:28AM Why Is Minim (MINM) Stock Up 43% Today? (InvestorPlace) +35.12%
Dec-20-23 08:30AM Joshua S. Horowitz Elected Chairman of the Board of Directors of BK Technologies (ACCESSWIRE) -24.45%
Nov-30-23 02:34PM Minim Inc. Responds to Unusual Trading (GlobeNewswire) +392.31%
10:52AM Minim (MINM) Stock Soars 778% After Receiving Nasdaq Deficiency Notice (InvestorPlace)
Nov-20-23 12:35PM Minim, Inc. Announces Receipt of Nasdaq Listing Deficiency Notice (GlobeNewswire) +8.34%
Aug-10-23 04:30PM Minim Announces CFO Resignation and Transition Plan (GlobeNewswire)
Apr-07-23 04:20PM Minim Announces CEO Transition (GlobeNewswire)
Minim, Inc. is the creator of intelligent networking products that dependably connect people to the information they need and the people they love. The company delivers smart software-driven communications products under the globally recognized Motorola brand and ZOOM trademark. Minim end users benefit from a personalized and secure WiFi experience, leads to happy and safe homes where things just work. The company was founded by Frank Blase Manning and Peter Robin Kramer in May 1977 and is headquartered in Manchester, NH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HITCHCOCK ELIZABETH CASH10% OwnerDec 06 '23Buy1.51743,3431,122,448743,343Dec 08 08:36 PM
HITCHCOCK JEREMY P.Executive ChairmanDec 06 '23Buy1.51743,3431,122,448743,343Dec 08 08:35 PM
PRTA - Prothena Corporation plc - Stock Price Chart
TickerPRTA [NASD, RUT]
CompanyProthena Corporation plc
CountryIreland
IndustryBiotechnology
Market Cap1.09BEPS (ttm)-3.25
P/E-EPS this Y-70.41%
Forward P/E-EPS next Y9.28%
PEG-EPS past 5Y6.83%
P/S12.25EPS next 5Y34.07%
P/B2.17EPS Q/Q-50.67%
Dividend-Sales Q/Q-97.69%
Insider Own13.69%Inst Own98.57%
Insider Trans-0.20%Inst Trans-4.11%
Short Float14.54%EarningsMay 08/a
Analyst Recom1.44Target Price64.75
Avg Volume549.44K52W Range19.65 - 77.13
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm's clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walker Karin LChief Accounting OfficerJan 24 '24Option Exercise13.535,00067,6505,000Jan 24 07:01 PM
Walker Karin LChief Accounting OfficerJan 24 '24Sale34.005,000170,0000Jan 24 07:01 PM
Walker Karin LChief Accounting OfficerDec 20 '23Option Exercise13.535,00067,6505,000Dec 20 07:17 PM
Walker Karin LChief Accounting OfficerDec 20 '23Sale37.195,000185,9520Dec 20 07:17 PM
Walker Karin LChief Accounting OfficerNov 30 '23Option Exercise13.535,00067,6505,000Nov 30 06:24 PM
COOT - Australian Oilseeds Holdings Limited - Stock Price Chart
TickerCOOT [NASD]
CompanyAustralian Oilseeds Holdings Limited
CountryAustralia
IndustryFarm Products
Market Cap26.24MEPS (ttm)-0.46
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.26EPS Q/Q-55.16%
Dividend-Sales Q/Q-
Insider Own81.92%Inst Own2.46%
Insider Trans0.00%Inst Trans-3.54%
Short Float2.12%Earnings-
Analyst Recom-Target Price-
Avg Volume71.65K52W Range1.06 - 11.96
Australian Oilseeds Holdings Ltd. engages in acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all the assets of, entering contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities. The company is headquartered in Cootamundra, Australia.
NXL - Nexalin Technology Inc - Stock Price Chart
TickerNXL [NASD]
CompanyNexalin Technology Inc
CountryUSA
IndustryMedical Devices
Market Cap8.06MEPS (ttm)-0.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y2.43%
P/S50.36EPS next 5Y-
P/B3.46EPS Q/Q-36.32%
Dividend-Sales Q/Q157.43%
Insider Own20.63%Inst Own0.85%
Insider Trans0.00%Inst Trans-
Short Float1.32%Earnings-
Analyst Recom-Target Price-
Avg Volume825.51K52W Range0.25 - 3.40
Nexalin Technology, Inc. designs and develops neurostimulation products. Its medical devices helps people with mental health illness. The company was founded by John Patrick Claude on October 19, 2010 and is headquartered in Houston, TX.
EVRI - Everi Holdings Inc - Stock Price Chart
TickerEVRI [NYSE, RUT]
CompanyEveri Holdings Inc
CountryUSA
IndustryGambling
Market Cap570.90MEPS (ttm)0.66
P/E10.31EPS this Y-18.03%
Forward P/E7.15EPS next Y27.32%
PEG0.52EPS past 5Y40.40%
P/S0.71EPS next 5Y20.00%
P/B2.46EPS Q/Q-82.37%
Dividend2.95%Sales Q/Q-6.64%
Insider Own3.22%Inst Own91.26%
Insider Trans-5.93%Inst Trans-1.68%
Short Float4.61%EarningsMay 08/b
Analyst Recom2.00Target Price12.00
Avg Volume1.23M52W Range7.18 - 16.08
Everi Holdings, Inc. engages in the provision of technology solutions to the casino, interactive, and gaming industry. It operates through the Games and Financial Technology Solutions (FinTech) segments. The Games segment focuses on leased gaming equipment, sales of gaming equipment, gaming systems, interactive solutions, and ancillary products and services. The FinTech segment provides access to cash at gaming facilities via ATM cash withdrawals, credit card cash access transactions and point of sale debit card cash access transactions, check-related services, fully integrated kiosks and maintenance services, compliance, audit and data software, casino credit data, and reporting services and other ancillary offerings. The company was founded on February 4, 2004 and is headquartered in Las Vegas, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EHRLICH DEAN AEVP, Games Business LeaderMay 21 '24Sale7.3711,14482,131184,627May 21 08:30 PM
Simmons DarrenEVP, FinTech Business LeaderMay 21 '24Sale7.376,89750,831190,425May 21 08:31 PM
EHRLICH DEAN AEVP, Games Business LeaderMay 20 '24Sale7.322,61419,134195,771May 21 08:30 PM
Simmons DarrenEVP, FinTech Business LeaderMay 20 '24Sale7.321,61911,851197,322May 21 08:31 PM
Simmons DarrenEVP, FinTech Business LeaderMay 19 '24Option Exercise0.006,5660198,941May 21 08:31 PM
110121314151617181920